Analyst Ratings for Halozyme Therapeutics (halo)
halo Rating Summary
halo Price Target Summary
- Highest: $115.00 (H.C. Wainwright)
- Lowest: $58.00 (Goldman Sachs)
- Average: $92.11
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$92.11 (-12.2%)
* Over Last 12-Mos
Rating Score: 6.8 / 10
Percentile Rank: 73%
Avg. $ Target:
$92.11 (-12.2%)
* Over Last 12-Mos
Rating Score: 6.8 / 10
Percentile Rank: 73%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/7/2026 | Leerink | David Risinger | Upgrade | Outperform (Market Perform) |
110.00 (83.00) |
85.76 (104.89) |
22.31% | Details |
| 5/20/2026 | JPMorgan | Jessica Fye | New Coverage | Neutral (N/A) |
70.00 (N/A) |
67.44 (104.89) |
55.53% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
